We would like to present a case with recurrent polimorphic ventricular tachycardia, that has prolongation of Q-U period and obvious U wave without prolongation of Q-T period.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Torsades de Pointes forms an important subgroup of ventricular tachycardia that usually occurs secondary to iatrogenic reasons.
📊
Key Findings & Data:Torsades de Pointes forms an important subgroup of ventricular tachycardia that usually occurs secondary to iatrogenic reasons.
💡
Conclusion & Impact:We would like to present a case with recurrent polimorphic ventricular tachycardia, that has prolongation of Q-U period and obvious U wave without prolongation of Q-T period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Torsades de pointes · Metronidazol · Elektrokardiyografi
Abstract
Torsades de Pointes forms an important subgroup of ventricular tachycardia that usually occurs secondary to iatrogenic reasons. We would like to present a case with recurrent polimorphic ventricular tachycardia, that has prolongation of Q-U period and obvious U wave without prolongation of Q-T period.
Özet
Torsades de pointes (TdP), polimorfik ventriküler taşikardilerin genellikle iatrojenik, sebeplere bağlı ortaya çıkan önemli bir alt grubudur. EKG’de QT süresi uzamaksızın, U dalgası belirginleşmesi ve Q-U süresi uzaması olan bir polimorfik ventriküler taşikardi olgusu sunmaktayız.
KARABAĞ, T., ALTUNKESER, B. B., TOKAÇ, M., ÖZDEMİR, K., DÜZENLİ, A. (2004). U wave and Q-T prolongation without Q-T prolongation: Predictor of torsades de pointes. Türk Aritmi Pacemaker ve Elektrofizyoloji Dergisi, Cilt: 2 - Sayı: 1, 57–60. https://ajindex.com/articles/395183
References (7)
Fontaine G, Frank R, Grosgogeat Y. Torsades de pointes: Definition and management. Mod Consepts Cardiovasc Dis 1982; 51: 103-8
Bednar MM, Harigan EP, Ruskin JN Am J Cardiol 2002; 1316-1319
Drugs causing prolongation of Q-T interval and torsades de pointes. Canadian Adverse Drug Reaction Newsletter. January 1998. Available at: (http://www.hc-sc.gc.ca/hpb- dgps/therapeut/zfiles/english/publicat/adrv8n 1 _e.html); 8(1). Accesed March 2000
Woosley RL. Drugs that prolong the Q-T interval and/or induce torsades de pointes http://www.dml.georgetown.edu/ depts/pharmacology/Torsades.html. Accesed March 2000
Smith WM, Gallagher JJ, 'Les Torsades de Pointes' An unusual ventricular arrhytmia. Ann Intern Med 1980; 93: 578-84
Makkar RR, Fromm BS, Steinman RT, et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993; 270: 2590-2597
Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690-695.